☰ Navigation Tabs
PawL-Derived Peptide PLP-12
NMR Experiment Experiment Type Sample Contents Solvent Ionic Strength pH Pressure Temperature (K) Spectrometer 1 2D 1H-1H TOCSY 20 ms 1.0 mg/mL peptide 90% H2O/10% D2O 1.2 mM 4.5 1 atm 298 Bruker AVANCE III 600 2 2D 1H-1H ROESY 1.0 mg/mL peptide 90% H2O/10% D2O 1.2 mM 4.5 1 atm 298 Bruker AVANCE III 500 3 2D DQF-COSY 1.0 mg/mL peptide 90% H2O/10% D2O 1.2 mM 4.5 1 atm 298 Bruker AVANCE III 600 4 2D 1H-13C HSQC 1.0 mg/mL peptide 90% H2O/10% D2O 1.2 mM 4.5 1 atm 298 Bruker AVANCE III 600 5 2D 1H-1H TOCSY 80 ms 1.0 mg/mL peptide 90% H2O/10% D2O 1.2 mM 4.5 1 atm 298 Bruker AVANCE III 600
NMR Spectrometer Information Spectrometer Manufacturer Model Field Strength 1 Bruker AVANCE III 600 2 Bruker AVANCE III 500
NMR Refinement Method Details Software simulated annealing YASARA
NMR Ensemble Information Conformer Selection Criteria structures with the lowest energy Conformers Calculated Total Number 200 Conformers Submitted Total Number 20 Representative Model 1 (closest to the average)
Computation: NMR Software # Classification Version Software Name Author 1 collection TopSpin 3.5 Bruker Biospin 2 data analysis Analysis 2.4.2 CCPN 3 structure calculation YASARA 16.7.22 Elmar Krieger